Zolgensma
NDC 71894-145, onasemnogene abeparvovec-xioi, kit, from Novartis Innovative Technologies Inc..
- Product NDC
- 71894-145
- Status
- Listed
- Labeler
- Novartis Innovative Technologies Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125694
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71894-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71894-145-11 | 71894014511 | 1 KIT in 1 CARTON (71894-145-11) * 8.3 mL in 1 VIAL (71894-115-01) * 1 mL in 1 POUCH * 5.5 mL in 1 VIAL (71894-110-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/68cd4f06-70e1-40d8-bedb-609ec0afa471
Use it
Look up 71894-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71894-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71894-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.